Bank of New York Mellon
AXN

Bank of New York Mellon’s Aoxing Pharmaceutical Company Inc. AXN Stock Holding History

Bank of New York Mellon’s Portfolio AXN Stock Details AXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-11,664
Closed -$5K – 4392
2017
Q1 		$5K Buy
+11,664
New +$5.01K ﹤0.01% 4272
2016
Q4 		– Sell
-50,592
Closed -$28K – 4345
2016
Q3 		$28K Sell
50,592
-544
-1% -$366 ﹤0.01% 4199
2016
Q2 		$33K Sell
51,136
-1,088
-2% -$737 ﹤0.01% 4236
2016
Q1 		$34K Sell
52,224
-3
-0% -$2 ﹤0.01% 4130
2015
Q4 		$35K Buy
+52,227
New +$65.6K ﹤0.01% 4229

Other funds holding AXN

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
EWM
Evercore Wealth Management New York $6.36B AUM 20.35% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $147B AUM 18.73% 1-Year Est. Return
FWM
Focused Wealth Management Newburgh, New York $1.15B AUM 24.81% 1-Year Est. Return

Bank of New York Mellon's AXN Position: Q2 2017 in Review

Bank of New York Mellon sold out of Aoxing Pharmaceutical Company Inc. (AXN) in Q2 2017, closing a stake of 11,664 shares — an estimated $5K sold.

Bank of New York Mellon first reported a position in AXN in Q4 2015 and held it in 5 quarters. The position peaked at $35K in Q4 2015. 7 funds tracked by Wall St. Rank hold AXN as of Q2 2017.

  • Bank of New York Mellon reported no remaining Aoxing Pharmaceutical Company Inc. position as of Q2 2017 after selling out during the quarter.
  • Bank of New York Mellon sold 11,664 Aoxing Pharmaceutical Company Inc. shares in Q2 2017, an estimated $5K.
  • Bank of New York Mellon first reported a position in Aoxing Pharmaceutical Company Inc. in Q4 2015 and held it in 5 quarters.
  • Bank of New York Mellon's Aoxing Pharmaceutical Company Inc. position peaked at $35K in Q4 2015.
  • 7 funds tracked by Wall St. Rank held Aoxing Pharmaceutical Company Inc. as of Q2 2017.

Based on Bank of New York Mellon's 13F filing for Q2 2017, filed 3 Aug 2017.